A cheap and common drug could end the misery of long Covid for millions, according to one of the only clinical trials of treatments for the condition.Metformin, taken by around 20million type 2 diabetics in the US, decreased the risk of a person developing long Covid by 42 percent if used while infected.Researchers at the University of believe the drug can suppress the replication of infected cells in the body — reducing the oxidative stress and inflammation believed to be at the heart of long Covid.
Load More
Load More